[{"data":1,"prerenderedAt":47},["ShallowReactive",2],{"q-nurse-113-2-medical-surgical-033":3},{"subject":4,"subjectSlug":5,"subjectFullName":4,"question":6,"related":23},"內外科護理學","medical-surgical",{"id":7,"webId":8,"year":9,"session":10,"subject":4,"number":11,"stem":12,"options":13,"answer":18,"answerNote":19,"images":20,"explanation":21,"freq":22},"nurse-113-2-內外科護理學-033","nurse-113-2-medical-surgical-033",113,2,33,"有關乳癌病人荷爾蒙治療之敘述，下列何者錯誤？",{"A":14,"B":15,"C":16,"D":17},"Letrozole（Femara）是轉移性乳癌第一線用藥，需服用 2～5 年","停經後婦女的荷爾蒙治療效果比停經前婦女好","雌性素受體（ER）或黃體素受體（PR）呈陽性者，治療效果較好","抗雌性素治療會有骨質疏鬆副作用，需定期做骨質密度檢查","A",null,[],"本題考點在於乳癌荷爾蒙(內分泌)治療的原則,屬反向題。Letrozole(Femara)屬芳香環酶抑制劑,適用於「停經後」荷爾蒙受體陽性乳癌,其作用是抑制周邊脂肪組織的雌激素生成,對停經前婦女卵巢仍大量製造雌激素者效果不佳,故 A 將其泛稱為「第一線」且服用 2–5 年的描述與適應族群\u002F療程不符,為相對錯誤敘述、即為答案。B 正確,停經後婦女雌激素主要來自芳香環酶,故此類治療效果較好。C 正確,ER 或 PR 陽性者對內分泌治療反應較佳。D 正確,抗雌激素治療降低雌激素會致骨質疏鬆,須定期骨密度追蹤。整體以「藥物適用族群與受體狀態」判別。",1,[24,28,31,35,39,43],{"webId":25,"stem":26,"number":22,"year":27,"session":22},"nurse-106-1-medical-surgical-001","有關巴金森氏病治療之敘述，下列何者正確？",106,{"webId":29,"stem":30,"number":10,"year":27,"session":22},"nurse-106-1-medical-surgical-002","有關巴金森氏病的護理指導，下列何者正確？",{"webId":32,"stem":33,"number":34,"year":27,"session":22},"nurse-106-1-medical-surgical-003","下列何者為出血性腦中風最主要的危險因子？",3,{"webId":36,"stem":37,"number":38,"year":27,"session":22},"nurse-106-1-medical-surgical-004","有關頸部脊髓損傷的神經性休克徵象，下列何者正確？",4,{"webId":40,"stem":41,"number":42,"year":27,"session":22},"nurse-106-1-medical-surgical-005","陳小姐診斷為腦下垂體腫瘤，進行經蝶骨腦下垂體切除術，術後出現尿崩症，下列敘述何者錯誤？",5,{"webId":44,"stem":45,"number":46,"year":27,"session":22},"nurse-106-1-medical-surgical-006","顱底骨折常出現的徵象，下列何者錯誤？",6,1783840783320]